2005 Annual Meeting | Cerebrovascular Disease: Advances in Stroke

Date Friday 04/15/05

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Gregory W. Albers, MD

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Upon completion:
Participants will become familiar with recent advances in medical, surgical, and interventional radiologic approaches to stroke treatment and prevention and learn the current guidelines for use of thrombolytic, anticoagulant, and antiplatelet agents in cerebrovascular patients.

The American Board of Psychiatry and Neurology has reviewed Cerebrovascular Disease: Advances in Stroke and has approved this product as part of a comprehensive lifelong learning program, which is mandated by the ABMS as a necessary component of maintenance of certification.

CME Available No CME available

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
09:00 AM - 09:40 AM		What is and isn't CNS Vasculitis Richard A. Bernstein, MD
09:40 AM - 10:20 AM		Update on the Management of Intracerebral Hemorrhage Christine A. Wijman, MD
10:20 AM - 10:35 AM		Break
10:35 AM - 11:15 AM		Management of Arteriovenous Malformations J. P. Mohr, MD, FAAN
11:15 AM - 12:00 PM		Intra-arterial Therapy for Acute Stroke Jeffrey L. Saver, MD, FAAN
12:00 PM - 01:15 PM		Lunch
01:15 PM - 01:55 PM		Anticoagulant, Antiplatelet, and Thrombolytic Therapy: Current Guidelines Gregory W. Albers, MD
01:55 PM - 02:35 PM		TIAs: Definition, Diagnosis, and Management J. D. Easton, MD, FAAN
02:35 PM - 02:50 PM		Break
02:50 PM - 03:30 PM		Modern Management of Carotid Stenosis Pierre Fayad, MD, FAHA, FAAN
03:30 PM - 05:00 PM		Interactive Case Presentations

Faculty Disclosures
Gregory W. Albers, MD	No disclosure on file
Pierre Fayad, MD, FAHA, FAAN	Dr. Fayad has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fayad has received personal compensation in the range of $0-$499 for serving as a Member Data Safety & Monitoring Committee with NINDS.
Richard A. Bernstein, MD	No disclosure on file
J. D. Easton, MD, FAAN	No disclosure on file
Christine A. Wijman, MD	No disclosure on file
J. P. Mohr, MD, FAAN	The institution of Dr. Mohr has received research support from NINDS Grant R01 NS099268 NIH-NINDS .
Jeffrey L. Saver, MD, FAAN	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.

��ɫ��

��ɫ��